{"entity":{"type":"insider","cik":"0001677141","url":"/insider/0001677141","json_url":"/insider/0001677141.json","name":"Kapadia Sandip","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2017-07-05","last":"2026-01-28","span_basis":"filed_date"},"name_variants":[{"name":"Kapadia Sandip","source":"filing","n_filings":14,"first_seen":"2017-07-05","last_seen":"2026-01-28"}],"transactions":[{"id":6221227,"accession":"0001677141-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001677141-26-000004","line_url":"/filing/0001677141-26-000004#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3746.0,"shares_display":"3,746","price_per_share":37.152,"price_display":"37.15","price_state":"stated","total_value":139171.392,"total_display":"139,171.39","shares_owned_after":24521.0,"shares_owned_after_display":"24,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-28","scope":"insider"},{"id":6114098,"accession":"0001677141-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001677141-26-000001","line_url":"/filing/0001677141-26-000001#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20961.0,"shares_display":"20,961","price_per_share":35.9159,"price_display":"35.92","price_state":"stated","total_value":752833.1799,"total_display":"752,833.18","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":4052791,"accession":"0001677141-25-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001677141-25-000008","line_url":"/filing/0001677141-25-000008#line-2","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":39.5448,"price_display":"39.54","price_state":"stated","total_value":790896.0,"total_display":"790,896.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-09","scope":"insider"},{"id":4438106,"accession":"0001677141-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001677141-25-000006","line_url":"/filing/0001677141-25-000006#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3427.0,"shares_display":"3,427","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":119945.0,"total_display":"119,945.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider"},{"id":4176620,"accession":"0001415889-25-022294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022294","line_url":"/filing/0001415889-25-022294#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21573.0,"shares_display":"21,573","price_per_share":36.4983,"price_display":"36.50","price_state":"stated","total_value":787377.8259,"total_display":"787,377.83","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":4146335,"accession":"0001415889-25-009936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-009936","line_url":"/filing/0001415889-25-009936#line-2","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6247.0,"shares_display":"6,247","price_per_share":32.4765,"price_display":"32.48","price_state":"stated","total_value":202880.6955,"total_display":"202,880.70","shares_owned_after":740.0,"shares_owned_after_display":"740","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":4146332,"accession":"0001415889-25-009936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-009936","line_url":"/filing/0001415889-25-009936#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":740.0,"shares_display":"740","price_per_share":33.1152,"price_display":"33.12","price_state":"stated","total_value":24505.248,"total_display":"24,505.25","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":4280602,"accession":"0001415889-25-002158","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-002158","line_url":"/filing/0001415889-25-002158#line-3","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1775.0,"shares_display":"1,775","price_per_share":38.0548,"price_display":"38.05","price_state":"stated","total_value":67547.27,"total_display":"67,547.27","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-28","scope":"insider"},{"id":4035510,"accession":"0001415889-25-001925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001925","line_url":"/filing/0001415889-25-001925#line-2","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Harmony Biosciences Holdings, Inc.","issuer_ticker":"HRMY","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CHIEF FINANCIAL OFFICER)","officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":40.1839,"price_display":"40.18","price_state":"stated","total_value":1004597.5,"total_display":"1,004,597.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-23","scope":"insider"},{"id":6497960,"accession":"0001209191-22-059462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-059462","line_url":"/filing/0001209191-22-059462#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":1.1929,"price_display":"1.19","price_state":"stated","total_value":5964.5,"total_display":"5,964.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-02","scope":"insider"},{"id":5205691,"accession":"0001104659-21-001123","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-001123","line_url":"/filing/0001104659-21-001123#line-3","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CFO and Treasurer)","officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2193.0,"shares_display":"2,193","price_per_share":24.47,"price_display":"24.47","price_state":"stated","total_value":53662.71,"total_display":"53,662.71","shares_owned_after":23764.0,"shares_owned_after_display":"23,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-05","scope":"insider"},{"id":3003176,"accession":"0001104659-20-136448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-136448","line_url":"/filing/0001104659-20-136448#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS, INC.","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (CFO and Treasurer)","officer_title":"CFO and Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1763.0,"shares_display":"1,763","price_per_share":32.78,"price_display":"32.78","price_state":"stated","total_value":57791.14,"total_display":"57,791.14","shares_owned_after":27158.0,"shares_owned_after_display":"27,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":2975539,"accession":"0001209191-20-015628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-015628","line_url":"/filing/0001209191-20-015628#line-1","is_derivative":false,"issuer_cik":"0001677141","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001677141","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":4373431,"accession":"0001144204-17-051416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-051416","line_url":"/filing/0001144204-17-051416#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":354.0,"shares_display":"354","price_per_share":58.8326,"price_display":"58.83","price_state":"stated","total_value":20826.7404,"total_display":"20,826.74","shares_owned_after":20215.0,"shares_owned_after_display":"20,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4949488,"accession":"0001144204-17-035813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-035813","line_url":"/filing/0001144204-17-035813#line-1","is_derivative":false,"issuer_cik":"0001270073","issuer_name":"INTERCEPT PHARMACEUTICALS INC","issuer_ticker":"ICPT","issuer_name_source":null,"issuer_url":"/issuer/0001270073","owner_cik":"0001677141","owner_name":"Kapadia Sandip","owner_url":"/insider/0001677141","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1431.0,"shares_display":"1,431","price_per_share":121.5927,"price_display":"121.59","price_state":"stated","total_value":173999.1537,"total_display":"173,999.15","shares_owned_after":20569.0,"shares_owned_after_display":"20,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802665","name":"Harmony Biosciences Holdings, Inc.","url":"/issuer/0001802665","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":8,"first_seen":"2025-01-23","last_seen":"2026-01-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Director","n_filings":2,"first_seen":"2020-03-03","last_seen":"2022-12-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Officer (CFO and Treasurer)","n_filings":4,"first_seen":"2017-07-05","last_seen":"2021-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001677141","retrieved_at":"2026-08-21T18:48:03+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}